Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy HSBC Holdings (HSBA) by Simon Watkins in The Motley Fool
- Buy SSE (SSE) by Berenberg
- Buy Town Centre Securities (TOWN) by Russ Mould in The Telegraph - Questor
- Hold GSK (GSK) by Russ Mould in The Telegraph - Questor
- Buy Unilever (ULVR) by Mark Rogers in The Motley Fool
- Buy Greencoat UK Wind (UKW) by Royston Wild in The Motley Fool
- Buy BlackRock Greater Europe Inv Trust (BRGE) by Lauren Almeida in The Times - Tempus
- Hold Tristel (TSTL) by Kevin Godbold in The Motley Fool
- Buy Golden Prospect Precious Metals Ltd. (GPM) by Nigel Somerville in ShareProphets
- Avoid SIG (SHI) by Steve Moore in ShareProphets
- Avoid Fonix (FNX) by Steve Moore in ShareProphets
- Watch British Land Company (BLND) by Jon Smith in The Motley Fool
- Sell React Group (REAT) by Hot Stock Rockets in ShareProphets
- Buy AstraZeneca (AZN) by Simon Watkins in The Motley Fool
- Buy Experian (EXPN) by UBS
- Neutral Rentokil Initial (RTO) by UBS
- Neutral Ashtead Group (AHT) by UBS
- Buy DCC (CDI) (DCC) by UBS
- Neutral RS Group (RS1) by UBS
- Buy Yellow Cake (YCA) by Citi
Avacta Group (AVCT) Share Price
Health Care Sector
NOTE: This is based on 58 open tips for Avacta Group (AVCT)
| Latest Bid : 60.00p | Latest Ask : 63.00p |
| High Today : 65.00p | Low Today : 60.06p |
| This Years High : 150.00p | This Years Low : 39.75p |
| Volume : 290,645 | MKT Cap : £226.17M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000
Avacta Group (AVCT) Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.Avacta Group (AVCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2024-09-17 10:35:00 17/09/2024 | -10.53% |
| Sell | Deutsche Bank | Premium Only | 2024-09-17 07:27:00 17/09/2024 | 7.35% |
| Sell | Tom Winnifrith | Premium Only | 2024-06-26 09:30:00 26/06/2024 | -40.00% |
| Hold | Deutsche Bank | Premium Only | 2024-06-19 07:24:00 19/06/2024 | 70.00% |
| Sell | Deutsche Bank | Premium Only | 2024-05-07 06:47:00 07/05/2024 | 12.09% |
Avacta Group (AVCT) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| GSA Capital Partners LLP | 0.78% | 10/07/2024 |
| Latest Bid : 60.00p | Latest Ask : 63.00p |
| High Today : 65.00p | Low Today : 60.06p |
| This Years High : 150.00p | This Years Low : 39.75p |
| Volume : 290,645 | MKT Cap : £226.17M |
Avacta Group Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Avacta Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2024-09-17 10:35:00 17/09/2024 | -10.53% |
| Sell | Deutsche Bank | Premium Only | 2024-09-17 07:27:00 17/09/2024 | 7.35% |
| Sell | Tom Winnifrith | Premium Only | 2024-06-26 09:30:00 26/06/2024 | -40.00% |
| Hold | Deutsche Bank | Premium Only | 2024-06-19 07:24:00 19/06/2024 | 70.00% |
| Sell | Deutsche Bank | Premium Only | 2024-05-07 06:47:00 07/05/2024 | 12.09% |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000